TAP
45
-5
NTRS
47
-3
OI
45
2
XYL
64
-2
TGNA
80
2
SCHW
55
-6
CSCO
60
2
FSLR
73
-3
CMI
67
-4
ADBE
46
-3
FMC
39
-4
MDT
60
3
EIX
59
-2
MSI
54
-3
AEE
45
4
WBA
38
7
FRT
58
2
ZION
55
-4
INTC
33
2
EMN
76
-2
TAP
45
-5
NTRS
47
-3
OI
45
2
XYL
64
-2
TGNA
80
2
SCHW
55
-6
CSCO
60
2
FSLR
73
-3
CMI
67
-4
ADBE
46
-3
FMC
39
-4
MDT
60
3
EIX
59
-2
MSI
54
-3
AEE
45
4
WBA
38
7
FRT
58
2
ZION
55
-4
INTC
33
2
EMN
76
-2
Financhill
Back

Sage Therapeutics Vs. Bowman Consulting Group Industry Stock Comparison

Sell
26

SAGE
Sage Therapeutics

Last Price:
12.17
Seasonality Move:
7.35%
Sell
24

BWMN
Bowman Consulting Group

Last Price:
30.35
Seasonality Move:
-0.83%
Sell
26
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy, Sell or Hold?

  • The current Sage Therapeutics [SAGE] share price is $12.17. The Score for SAGE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Bowman Consulting Group (BWMN) is a Sell

Is Bowman Consulting Group a Buy, Sell or Hold?

  • The current Bowman Consulting Group [BWMN] share price is $30.35. The Score for BWMN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • BWMN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SAGE Stock Price Chart

What is Sage Therapeutics's stock price today?

  • The Sage Therapeutics share price today is $12.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight buying pressure.

BWMN Stock Price Chart

What is Bowman Consulting Group's stock price today?

  • The Bowman Consulting Group share price today is $30.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BWMN is experiencing selling pressure, which indicates risk of future bearish movement.

SAGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.21 Sell
Relative Strength Index (14 RSI): 32.47 Sell
Chaikin Money Flow: 195626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.45 - 15.19) Sell
Bollinger Bands (100): (15.75 - 24.83) Sell

BWMN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 41.68 Sell
Chaikin Money Flow: -60291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.51 - 32.55) Sell
Bollinger Bands (100): (30.77 - 36.53) Sell

SAGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.76 Sell
20-day SMA: 13.26 Sell
50-day SMA: 16.59 Sell
200-day SMA: 20.56 Sell
8-day EMA: 12.64 Sell
20-day EMA: 13.61 Sell
50-day EMA: 16.11 Sell
200-day EMA: 22.93 Sell

BWMN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.55 Sell
20-day SMA: 31.45 Sell
50-day SMA: 34 Sell
200-day SMA: 31.53 Sell
8-day EMA: 31.55 Sell
20-day EMA: 31.89 Sell
50-day EMA: 32.84 Sell
200-day EMA: 31.59 Sell

Sage Therapeutics Earnings Growth & SAGE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.15 per share, an increase this year of $3.05 per share, and an increase next year of $1.02 per share.

Bowman Consulting Group Earnings Growth & BWMN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.34 per share.

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bowman Consulting Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):